MX2017005650A - Composicion de antigeno para detectar enfermedad de chagas. - Google Patents

Composicion de antigeno para detectar enfermedad de chagas.

Info

Publication number
MX2017005650A
MX2017005650A MX2017005650A MX2017005650A MX2017005650A MX 2017005650 A MX2017005650 A MX 2017005650A MX 2017005650 A MX2017005650 A MX 2017005650A MX 2017005650 A MX2017005650 A MX 2017005650A MX 2017005650 A MX2017005650 A MX 2017005650A
Authority
MX
Mexico
Prior art keywords
cruzi
polypeptides
composition
chagas disease
antigen composition
Prior art date
Application number
MX2017005650A
Other languages
English (en)
Inventor
Scholz Christian
Roessler Dieter
Muench Peter
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2017005650A publication Critical patent/MX2017005650A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/005—Trypanosoma antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a una composición de polipéptidos adecuados para detectar anticuerpos contra Trypanosoma cruzi (T. cruzi) en una muestra biológica aislada que consiste de tres polipéptidos 1F8, JL7 y Cruzipain. Es también parte de la invención un método de producción de una composición soluble e inmunorreactiva de los polipéptidos adecuados para detectar los anticuerpos contra T. cruzi, utilizando la composición de los polipéptidos. Además, la invención se refiere a los métodos para detectar anticuerpos específicos para T. cruzi en una muestra aislada, en donde una composición de los polipéptidos de T. cruzi es utilizada así como un kit de reactivos que comprende la composición de los polipéptidos de T. cruzi.
MX2017005650A 2014-11-06 2015-11-04 Composicion de antigeno para detectar enfermedad de chagas. MX2017005650A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14192004.1A EP3018479A1 (en) 2014-11-06 2014-11-06 Antigen composition for detecting Chagas disease
PCT/EP2015/075691 WO2016071392A1 (en) 2014-11-06 2015-11-04 Antigen composition for detecting chagas disease

Publications (1)

Publication Number Publication Date
MX2017005650A true MX2017005650A (es) 2017-06-29

Family

ID=51932184

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017005650A MX2017005650A (es) 2014-11-06 2015-11-04 Composicion de antigeno para detectar enfermedad de chagas.

Country Status (8)

Country Link
US (1) US10094828B2 (es)
EP (2) EP3018479A1 (es)
JP (1) JP6763855B2 (es)
CN (1) CN107003309B (es)
BR (1) BR112017006569A2 (es)
ES (1) ES2705429T3 (es)
MX (1) MX2017005650A (es)
WO (1) WO2016071392A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3018479A1 (en) * 2014-11-06 2016-05-11 Roche Diagniostics GmbH Antigen composition for detecting Chagas disease
US20220119789A1 (en) * 2019-02-08 2022-04-21 Tokyo Institute Of Technology Enzymatic mutant suitable for homogeneous immunoassay method
CN111751416A (zh) * 2020-07-03 2020-10-09 福建中医药大学 一种新型的美洲大蠊多肽快速检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0976763B1 (en) * 1998-07-30 2003-11-05 Innogenetics N.V. Antigens and immunoassays for diagnosing Chagas' disease
PE20050942A1 (es) 2003-12-04 2005-11-10 Louis V Kirchhoff Polipeptidos recombinantes para diagnosticar la infeccion con el trypanosoma cruzi
EP2182979A4 (en) 2007-07-30 2010-09-08 Univ Georgia DIAGNOSTIC TEST OF TRYPANOSOMA CRUZI INFECTION
WO2010142829A1 (es) * 2009-06-12 2010-12-16 Consejo Superior De Investigaciones Científicas (Csic) Método de obtención de datos útiles para el diagnóstico diferencial de la enfermedad de chagas, y para evaluar la respuesta al tratamiento
EP3018479A1 (en) * 2014-11-06 2016-05-11 Roche Diagniostics GmbH Antigen composition for detecting Chagas disease

Also Published As

Publication number Publication date
EP3215848A1 (en) 2017-09-13
BR112017006569A2 (pt) 2018-01-16
US20170248597A1 (en) 2017-08-31
EP3018479A1 (en) 2016-05-11
CN107003309A (zh) 2017-08-01
EP3215848B1 (en) 2018-10-10
CN107003309B (zh) 2020-05-19
JP2017534055A (ja) 2017-11-16
WO2016071392A1 (en) 2016-05-12
JP6763855B2 (ja) 2020-09-30
ES2705429T3 (es) 2019-03-25
US10094828B2 (en) 2018-10-09

Similar Documents

Publication Publication Date Title
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
HK1243207A1 (zh) 用於分類生物樣本﹑包括分析的優化和相關性的使用的方法和系統
AU2017228470A8 (en) Combination therapy with anti-CD73 antibodies
MX2016013261A (es) Metodo para la cuantificacion de huevos de parasitos en las heces.
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EP3470842A4 (en) MEMBRANE CARRIER FOR LIQUID SAMPLING TEST KIT, LIQUID SAMPLING TEST KIT AND METHOD FOR PRODUCING A LIQUID SAMPLING TEST KIT
EP3270152A4 (en) KIT FOR SAMPLE PREPARATION FOR THE DETECTION OF MONOCLONAL ANTIBODIES
IL291325A (en) Anti-klk7 antibodies, anti-klk5 antibodies, multispecific anti-klk5/klk7 antibodies and methods of use
BR112015003032A8 (pt) anticorpos isolados,ácidos nucleico isolados,célula hospedeira,método de produzir um anticorpo,imunoconjugado,formulação famacêutica,uso do anticorpo e método de tratamento de um indivíduo.
MX2019004940A (es) Uso de beta-catenina como un biomarcador para el tratamiento de canceres que usan el anticuerpo anti-dkk-1.
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
BR112016028838A2 (pt) anticorpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica, métodos de detecção de lgr5 humano em uma amostra biológica, de detecção de um câncer, de identificação de um paciente com câncer, de seleção de um paciente com câncer para tratamento com um imunoconjugado e de tratamento de um paciente com câncer
EA201991506A1 (ru) Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов
BR112019006862A2 (pt) dispositivo de análise e método para testagem de uma amostra
PT3155421T (pt) Recipiente para determinar analitos e/ou parâmetros físicoquímicos, bem como para determinar o sedimento urinário na urina, e método de análise completa da urina utilizando este recipiente
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
MX2017005650A (es) Composicion de antigeno para detectar enfermedad de chagas.
EP3527669A4 (en) Kit for Quantitative Analysis of Hemoglobin A1C
EP3467498A4 (en) MONOCLONAL ANTI-HUMAN HEMOGLOBIN ANTIBODY OR ANTIBODY KIT, INSOLUBLE CARRIER PARTICLE TO WHICH THE MONOCLONAL ANTI-HUMAN HEMOGLOBIN ANTIBODY IS IMMOBILIZED, AND MEASURING REAGENT AND MEASURING METHODS USED THEREOF
EP3112864A4 (en) Urine sample analysis method and reagent kit for urine sample analysis
EP3112862A4 (en) Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis
EP3112863A4 (en) Method for urine sample analysis, reagent for urine sample analysis, and reagent kit for urine sample analysis
MX2016017136A (es) Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
EP3508840A4 (en) STANDARD REAGENT KIT FOR DIALYSIS LIQUID ANALYSIS AND AQUEOUS SOLUTION FOR STANDARD REAGENTS, DIALYSIS LIQUID, AND LIQUID REFILL FOR ARTIFICIAL KIDNEY